Development of Stem Cell-Derived Immune Cells for Off-the-Shelf Cancer Immunotherapies

Cell-based cancer immunotherapy has revolutionized the treatment of hematological malignancies. Specifically, autologous chimeric antigen receptor-engineered T (CAR-T) cell therapies have received approvals for treating leukemias, lymphomas, and multiple myeloma following unprecedented clinical resp...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yan-Ruide, Dunn, Zachary Spencer, Zhou, Yang, Lee, Derek, Yang, Lili
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700013/
https://www.ncbi.nlm.nih.gov/pubmed/34944002
http://dx.doi.org/10.3390/cells10123497

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700013/
https://www.ncbi.nlm.nih.gov/pubmed/34944002
http://dx.doi.org/10.3390/cells10123497

Ejemplares similares